Objective: (1) To evaluate whether the Nine Items Questionnaire (WOQ-9) for the detection of wearing-off (WO) in Parkinson Disease (PD), by means of its screening ability, is a helpful tool to assist neurologists in diagnosing WO; (2) To determine the sensitivity and the specificity of a free Brazilian Portuguese translation of WOQ-9. Method: A sample obtained by convenience included 60 patients. The WOQ-9 was answered by the patients themselves before their routine consultations. The detection of the WO by the WOQ-9 was compared with the neurologist assessment. Statistical significance was 5%. Results: The WOQ-9 showed sensitivity of 100%, specificity of 10.3%, positive and negative predictive values of 54.4% and 100% respectively. The identification of WO by the WOQ-9 was congruent in 54.5% of cases with neurological evaluation. Conclusion: The WOQ-9 is a convenient screening tool to aid physicians to detect WO in PD patients, and it is a quick and easy self-administered questionnaire.Keywords: Parkinson's disease, levodopa, wearing-off, questionnaire.
RESUMOObjetivo: (1) Verificar se o QuestionĂĄrio de Nove Itens (WOQ-9) para detectar wearing-off (WO) na doença de Parkinson (DP), pela sua capacidade de triagem, seria Ăștil aos neurologistas na identificação de WO; (2) determinar a sensibilidade e especificidade da versĂŁo livre em PortuguĂȘs Brasileiro do WOQ-9. MĂ©todo: Ao todo 60 indivĂduos com DP compuseram uma amostra obtida por conveniĂȘncia. Os prĂłprios pacientes responderam ao WOQ-9 antes de suas consultas rotineiras. A detecção de WO pelo WOQ-9 foi comparada com a avaliação neurolĂłgica. A significĂąncia estatĂstica foi 5%. Resultados: O WOQ-9 apresentou sensibilidade de 100%, especificidade de 10,3%, valores preditivos positivo e negativo de 54,4% e 100% respectivamente. A identificação de WO pelo WOQ-9 foi congruente em 54,5% dos casos com a avaliação neurolĂłgica. ConclusĂŁo: O WOQ-9 Ă© um mĂ©todo de rastreamento Ăștil para identificar WO em pacientes com DP, e Ă© um questionĂĄrio de autoavaliação cuja aplicação Ă© fĂĄcil e rĂĄpida.Palavras-chave: doença de Parkinson, levodopa, wearing-off, questionĂĄrios.The treatment of Parkinson's disease (PD) remains a major challenge spite of the increasing therapeutic arsenal in recent decades and progressing knowledge of its pathophysiology. Levodopa (LD) remains the most effective and widely prescribed drug in the symptomatic treatment of PD 1 . Currently it is acknowledged that up to 50% of patients have motor fluctuations after two years of the introduction of LD or another dopaminergic agonist (DA) 2,3 . The long-term use of levodopa leads to complications directly related to the duration of the treatment. Such complications include motor symptoms (MS) and non-motor symptoms (NMS). The most frequent motor complications are the motor fluctuations and dyskinesias. Wearing-off (WO) is one subtype of motor fluctuation and occurs over time, when the effectiveness of a dose of dopaminergic agonist tends to wear off earlier than before. For confirmation of this phenomeno...